Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Evelo Biosciences Inc

EVLO
Current price
0.0004 USD 0 USD (0.00%)
Last closed 0.0004 USD
ISIN US2997341035
Sector Healthcare
Industry Biotechnology
Exchange PINK
Capitalization 7 593 USD
Yield for 12 month -99.88 %
1Y
3Y
5Y
10Y
15Y
EVLO
21.11.2021 - 28.11.2021

Evelo Biosciences, Inc., a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis. The company is also developing EDP1867, a non-live pharmaceutical preparation for single strain of Veillonella parvula, which is in Phase 1b clinical trial; EDP2939, an investigational oral biologic for the potential treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts. Address: 620 Memorial Drive, Cambridge, MA, United States, 02139

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

10 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

-793 000 USD

Last Quarter

-1 616 000 USD

Key Figures EVLO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -69 674 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -83.25 %
PEG Ratio
Return On Equity TTM -6232.76 %
Wall Street Target Price 10 USD
Revenue TTM
Book Value -1.42 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -15.64 USD
Diluted Eps TTM -15.64 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics EVLO

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History EVLO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:20
Payout Ratio
Last Split Date 30.06.2023
Dividend Date

Stock Valuation EVLO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -0.3877
Price Book MRQ 3.5113

Financials EVLO

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators EVLO

For 52 weeks

0.0001 USD 0.76 USD
50 Day MA 0.0015 USD
Shares Short Prior Month 156 444
200 Day MA 0.023 USD
Short Ratio 0.12
Shares Short 430 098
Short Percent 2.22 %